Cardiac Imaging in Systemic Disorders: the ORACLES Registry
Starting soon
Conditions studied: Lupus
In brief
Autoimmune diseases affect a total of 5 to 10% of the population. These diseases are associated with an increased risk of developing cardiovascular pathologies. Modern cardiac imaging tools could provide a better understanding of these complications, enabling earlier diagnosis and detection of patients most at risk. Yet, the diagnostic and prognostic value of multimodal cardiac imaging in these diseases is under-researched. The current registry aimed at investigating the diagnostic and prognostic value of cardiac imaging in autoimmune and systemic disorders.
Key facts
- Study ID
- NCT07134166
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 1500
- Starts
- 2026-11-01
- Expected to finish
- 2046-11-01
- Last updated by the study team
- 2026-02-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Suspected or diagnosed autoimmune, inflammatory and/or systemic disease.
- Cross-sectional cardiac imaging including either nonenhanced cardiac computed tomography, enhanced coronary angiogram-computed tomography, or cardiac magnetic resonance imaging
You may not qualify if…
- Age < 18 years
- Objection to study participation
- Patient under legal protection
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.